The store will not work correctly when cookies are disabled.
N-(1-acetyl-6-methyl-4-thia-1,2-diazaspiro[4.5]dec-2-en-3-yl)acetamide
ID: ALA4292187
PubChem CID: 145986702
Max Phase: Preclinical
Molecular Formula: C12H19N3O2S
Molecular Weight: 269.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C2(CCCCC2C)S1
Standard InChI: InChI=1S/C12H19N3O2S/c1-8-6-4-5-7-12(8)15(10(3)17)14-11(18-12)13-9(2)16/h8H,4-7H2,1-3H3,(H,13,14,16)
Standard InChI Key: AKBMCVVTLGXZSU-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
4.5111 -17.4788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8012 -17.0702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0963 -17.4784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0951 -18.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8050 -18.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5161 -18.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1737 -17.9656 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8385 -17.4903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5897 -16.7092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7733 -16.7078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6140 -17.7480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2249 -17.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0004 -17.4629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0604 -16.4048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2962 -16.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6322 -15.2994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4831 -16.1258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2249 -18.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 1 1 0
8 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
10 15 1 0
15 16 2 0
15 17 1 0
6 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.37 | Molecular Weight (Monoisotopic): 269.1198 | AlogP: 1.90 | #Rotatable Bonds: ┄ |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.69 | CX Basic pKa: ┄ | CX LogP: 1.82 | CX LogD: 1.82 |
Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -0.57 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |